OPRK1 and alcohol abuse: PALM was previously employed to quantitatively characterize the differential effects of pharmacologically relevant concentrations of ethanol and naltrexone, an opioid receptor antagonist and drug used to treat alcohol use disorders, on the lateral nano-organization of mu and kappa opioid receptors (MOR and KOR, respectively).